Skip to main content
IDWeek 2021 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

Christine Dahlke, PhD

Senior Post Doc
Universitätsklinikum Hamburg Eppendorf
Hamburg, Germany

Christine Dahlke studied biomedicine with a focus on virology. Her main interest is the interplay between human pathogenic viruses and the immune system. Currently she is a researcher working for the Medical University of Hamburg-Eppendorf and the Bernhard-Nocht-Institute for Tropical Medicine in Germany. In addition, she is working for the German Centre for Infection Research (DZIF).

Her research work focuses on the development and testing of vaccines against infectious diseases, in particular in the context of phase I clinical trials. Her main interests includes the immune response upon vaccination, especially the dynamics of the innate immune response after vaccination as well as the induction of T-cell responses.

She has been involved in several first-in-human studies evaluating the immunogenicity of vaccines against emerging infections (VSV-EBOV, MVA-MERS-S, MVA-SARS-2-S). Currently, she is involved in testing the MERS vaccine MVA-MERS-S in a Phase Ib trial funded by CEPI. Since 2020, Christine Dahlke has been involved in the development and testing of a novel vaccine against COVID-19 in two Phase I trials.



I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentation(s):